Menu
GeneBe

MYO1D

myosin ID, the group of Protein phosphatase 1 regulatory subunits|Myosin heavy chains, class I

Basic information

Region (hg38): 17:32492521-32877177

Links

ENSG00000176658NCBI:4642OMIM:606539HGNC:7598Uniprot:O94832AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

No genCC data.

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the MYO1D gene.

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the MYO1D gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
2
clinvar
3
clinvar
5
missense
49
clinvar
2
clinvar
2
clinvar
53
nonsense
0
start loss
0
frameshift
0
inframe indel
0
splice donor/acceptor (+/-2bp)
0
splice region
3
3
non coding
1
clinvar
1
Total 0 0 49 4 6

Variants in MYO1D

This is a list of pathogenic ClinVar variants found in the MYO1D region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
17-32494815-G-C not specified Likely benign (Dec 07, 2021)2344203
17-32494830-G-A not specified Uncertain significance (Mar 01, 2023)2462450
17-32531950-CATACAATGGCACTCACTCTTAATGGCTACATCATCATCTGGCTGCAAACCACCATGACCAAGTAGCCAATCTGTTGGGAAGTGGCAGCTAATCCTTTGTGCTACAGGATAAGGACATTCTCAAGGTCCTGCACTGTGCCATCCCTGGCTCCAATGTGGCTGCTGAGAATTCAGCTGACAATTTCCAATTTAAGCGGTGAGAAGTCAGTTCTTTAAAACAAGTATCAGACCAAGGAAGGATAAAAACAGCCCCCTCTGTGAATTATTTTCTGATTTGCACCTTTCTTTTACCTTTCAACCAGAAATGATCTGCTTTCTTTTGAACTTCTACACAAGTTTATATCTGCCGCCTCAAGCAGGCTTACTCAATGACACCAATTCAGAAATTAAAATATTCTTTGTAGCAGAATAAACAGTGTAGTGTCAACGTCTCATGGTGACCCACGGCCTTAAAAGAGGTGCCCTTAGTCGGGCGAATATTAAAAGTAGAAGAAGGGGCCGGACACAGTGGCTCATGCCTGTAATCCCAGCACTTTGGGAGGCTGAGGTGGGTGGATCATGAGGTCAGGAGATCGAGACCATCCTGGCTAACAAGGTGAAACCCCGTCTCTACTAAAAATACAAAAAATTAGCCGGGCGTGGTGGCGGCGCCTGTAGTCCCAGCTACTCGGGAGGCTGAGGCAGGAGAATGGCGTGAACCTGGGAGGCGGAGCTTGGAGTAAGCCGAGATTGCCACTGCACTCCAGCCTGGGCGACAGAGTGAGACTCCGTCTCAAAAAAAAAAAAAAAAAAAACCAAACGAGTGCACGAGGCTGATATGCTCATTTTACCACAGCAGGGCTGAGGCCCTCCACTCCCATTGTTTGGTGCAAAACAACTCTATTTGGCTTTATCTACACTAAGGTTATTTTGTTTGGTGGTTACAAAATGAATGACAGCAGGTCCTCTTCAAGAAGTCAGACTTGATCATCCCATCTTACTTCCCTGGGTTTTTCAAATCATTGAATTCTGTCAATAGTTGGTTTTCTGCCAACTATTGAATAAGATCATGATGGCTTTATGACACTCTCTCACATGGCTTTCAAGGCACAGCGTGTTCTGGTCTTCCTACTCTTTTACCATTCCTTTTGTCTCCTCTACCCTCTTCTTCCATTCGCAGGACTTCTCTATATATTTTTTAGATCTATGGCAAAATGAAACTTTATTTTGTAAATTGATACTCAGGTAATTCCATATGCTGATAACTCCCAAATCTATACCTCTAGCCCATTTTAATTCCAAACCTTATATTCAGCTGCCTCTTAGATATTTGCCCTTGGATAAGAGACAGCTGGGTTCATGGCCACCCATCACCCAAGCCAGAAGCCTGAGGGCCCTCCATGATGTCACCTCCTTCCCACTCCACAGCAATCCATCACCAAATCCTGAAGATTTTACCTCCAAAACCTGTTTCAAACCCACCTTCTCTTCTTTCCTCCCTTACTACACTTCACTACTCAGACTCATCAGATCTCACCTGAAGCATTTTAACAGCTGCTGCCTGCCACCCACTCTTCAAGCTGCAACCAGAATGATCTTACTAAAGCACACGTCTCTAAGCCATAAATCTGATTTCCTGCTTGAAACTCTCTTTTAGCTCCTCAATTCTCTCACGAAAAAGACCAAGCTCCTCTGGGTGTCTCTGTGATCCGCTGACCTCTCCAGCTCCCAGGCCTCCTGCTCCTTCCCAGCTCTCCAGGCTCCAGCCCTACTCCACTGTTTTCAGTTCCACCATGTGCTGAGCTCTCTGCTCCCTCCTGGCTTTCATACTTGCTCTTCCATTGGATAACACACACTTTCTTCTTTGCCCGTACCCTATTTGAAGTTACCCTAAAAAAATATGAAGTGTTACAAATATTTATTATAAAGATGCTCATCATAGCATAAATTAAAATTAAAAATGGGAAATTATCAAAATGCCCAATAAACAAAAATTTTTAAATGACTGCATAAAGTTTTCTGTTAATAGGAAATTACTTGTAGTATATTAAATGAGAAAATCAACTTGTGAAACCTGCTTTCTATCATGACTTCATAGCTACTTAAATAGGATAGTAATAGTAATTTCTGCACGGCAAAATTATAGCTGACTTAAATTTTTTCTTTATAAAGTAATTTTTTAAAGTTTTCCAACATTTCCCCATCCATATGCAATAATTACTTTTATTACATTTTTAAAATTAATTAATTAATTTAGAGATGGGGTCTCTCTCTGTCACCAAGGCTGGAGTGCCGTGGTGTGATCATAGCTCACTGCAGCATTGAATTTCTGGGCTCAAGTGATTCTCCTGCCTCATCCTCCTGAGTATCTGGAACTACAGGCATGTGCCACCATACCCACCTAATTTTTTAATTTTTTATTTTTATAGAGATAAGGTCTTGCTATGTTGCCCAGGCTGGTCTTGAAGTCCTGGCCTCAAGTGATTCTCCCATCTCAGCTTCATAAAGTGTTGGGTTTACAGGTATGAGCCACTGCGCCCAGCTGGAAAAATATATTTTAAAAGAAGAACACCCCTAAGCAAGGTAATGAGGGCACATATAGACACACAGCAAAGATTCTATTTCTCAAGGAGGAATGTTTTATTTGGAAAGTTTAAATCCTTAATGGGTATGAGATCTAGAGGCTTATCAGTGAGTCCTATAATAATCTGTTGCAAAGGGCGAAGTACAAAAAACAGCTGAAGAGTGCGGCGGAAGCTTCTGCTGATGTTTCTCTGACAAATGCTGGGGCTAATATTAATTCCTTGTTTTTGGGATGTGTGCTTCCATTACTGAAGAAATCCCCCCCTTTTTCTCTTTACACCCCGTAGATGTGAGACCAGCTGGAGGGCCACAAGAAGGAATGGAATTGAGTGAGCGAAGTACAGTTAAATAAATCTTAAAAACCCCCAGCTGCTGTGCTTCAGTCAACAGGGAACAAGAGGTGCCATTTTAGTCAATCTGTGTGCCCAACTACGTATAGAGAATGGAAAGTTAACACACAAACGTTTTGTTCTTTAGAAAAATGAAAATCATTCGGCTAAGTCCATACAGATATATCTAGTGGCCAGTTGTGAGAAGTCAATCCTTGCAAAGTAATACAAGACATTTGGTGTGGACCTGAGAATATTAAATTTAAGGACAGTTTTCCACCAAATCAAGCATGTATGTTATTTCTATTAGAGGTTCTTTTTCAGTCTTAATTAAATTAAAAGTTTAATCTGTAAACCGTTAGAAGTGAATGGCATACTTTGGGAAAATGAGGCCAAACTTTTAGCTTATGTGAAAATATTTTAAAGCATAAAACTGAAAATGCAACATCTTTTGCTCACTTAAGTATAATTGCAGATTAAATTTTCACTTTATGACCTAGTACATAGCACTTGCAACGTAAACCATGTAATAATAATTAAAAACACACTTTTTGAAACATAGGCTTCAATCTCTTTGAAGAGAGATTCAATACATTTGAAGAGAGAAACAATACATTGTACTTGTGGCCGGGCGCGGTGGCTCACGCCTATAATCCCAGCACTTTGGGAGGCCAAGGTGGACGGATCACAAGGTCAGGAGTTCAAGACCAGCCTGGCCAACATGGTGAAACCCCATCTCTACTAAAAACACACACAAAAAATTAGCTGGGTGTGGTGGTGGGCACCTGTAATCCCAGCTACTCAGGAGGCTGAGGCAGGAGAATCGCTTGAACCCAGGAAGCGGAGCTTGCAGTGAGCCAAGATTGTGCCACTGCACTCCAGTCTGGGGGACAGAGCAAGACTCCATCTCAACAAAACAAAACAAAACAAAACAAAAATCGTACTTATAGAATATTTATACAAAACTCAATAGCGTTTAGATAATATCTTTGAGGATCTCAGGGTGTTTTACCTGCAGAAATAAGACTGTAGTAACTTGAGGGAGAAGGGCAAATTTCTTTTTTAAGCTTAACTCTATTCCTGCAGAGAGTGTTTGTACTCAAAGCCATGAGAGGCAGCGCATAGCTGCAGACTGGAAGAGTGCAGACAGACAAGAGTTATGGGTCTCCCAGGATACAGACTCTTTTTTTTGTTTTTTGTTTTTCTTTTTGAGATGGAGTCTTGCTCTGTTGCCCAGGCTGGAGTGCAGTGATATGATCTTGGCTCACTGCAACCTCCGCCTCCTGGGTTCAAGAGATTCTCCTGCCTCAGCCTCCCGGAGTAGCTGGGATTTACAGGTGCAAGCCATCACACCTGGCTAATCTTTGTATTTTTAGTAGAGACAGGGTTTCACCATGTTGGCCAGGCTGGTCTCGAACTCCTGACCTCAAGTGATCCATCCACCTCGGCCTCCCAAAGTGCTGGGATTGCAGGCATGAGCCACTGTGCCTGGCCCCAGGATACAGACTCTAATTCTATTATTTTCTAGGTCTAAAAAAGGAAACCTATATTAAATCACAAGTCATATCTTGAAGAGGGAAAACTAAAAGAAGATTCTATTGTATCAGGTCATTTTAAACCCGAAACTAACTTTTATTATCATGGCCGAATTAGTGGGTTCTTACTGGTTTAGATATTAAAACGAATCATAAATATGGCTGTTTGGCTTATATGAGTTATAGATCTTATGTGCTGGCTTAAATTCCTAAGTTTTCAAGTGGATAATTCTAAAGACAACGCCAATTAATTAGTTTCCCAGAATTAGATTTAAGCTGGGAAATTAATGATAGTATGAATAAGAAAATATTATGCATTATATTTTTCATTTTAAAGTTTGAAATTATTTCTTAGAATCGGATCTGGGTCACGGCTGTAGAATTTTCCATTCGATATCCTTAAACATTGGCAACATTCCAAAAATTGTTACTGATTCCTTTTAAGCTTTATTACCCAGGATTTCATTTTGGTGGTTAGGAAAAAAGTTCCATGAATTGCATCCTTTCACAGTTAGAAATCCAAGAGTTCACACTTCTTGTCAGCAGGAAGTGGAGGTTGGGAAGAGTTCTATTTTTGGAGTTGAAAGGCCACCTTTGACCCAGAAAATGTGTGGTTGGATGAAAGACGTTTCTCTGTTCTGTCTTACTTGATTTGCCCAAGGAATGGAGAAACATCTAAGAGTGCAACTTCAGCAGACTTGTTTCCTCCTAGGGCCGGAAGATGACCTATATTAATGACATCTAAAGAATTTTAGATTTTCAAGTGTTTTTTCAGTCCCGTGTGGCCCATGTTACAGTCATTTCAATTTAGAGTATTCAAAACCTTCCAAATTGAAATATTCATAGTGTCCCAAGATATGAGGGCCACGATTTATTCTTCTATATCAGGGGCTGGGAAACTAAGACCCAGGGCCAAATCTGGTTGCCTGTTTTTGTAAATAAAGTTTTACTGGAACACAGCCATGTCCATTCATTTCCATATTGTCCGTGGCTGCTTTTGTGACACAATGGAAGAGCCGAGTACTTGTTACAGGGACCATATGGTCTGCAAAGCCTAAGATATTTATTATCTGGCTCTTTACAGAAAAAAGTTTGCTGACTCCAGGTTTAGATGATAAGGAATTGAAGAGAAGGTCTACAGATAGAGTGATGTCAAAGAGCAGGGGCTACACATGCCAGTATCATAAATGTTTAGTTTTTAGGGTCTAATTGCTTTTTATAATTAGCCTAAGACTTGACAAACAACATTTAAATACTCCAATTATGAAATGACCAGTTTGAACTGAGGGTTGTCCATTAGCATAGCGGTCCATAGAGAGAGAAATGAATCCATAAGAAGGAAATGTCATCCTAGTACGCTACCTGGCTCTGAAGGAAACAATGCTTACAAAATCATAGTAATATAAATGTCAGTTATTGGGTTTTGGCTTTAGAATCAATCACCAAAGTGGAAAACAATATAAATATTAATATTAACAATGTAAAAGTAAAGCTATAGTTGTCAAAAGTTCAGAGAGGGACATGGAGCAGTAAGGAGAAAATCTGGGCCACTTATATCTTCATTTGACATGGTGAGTCAAGGGGGTCTGAAGTTGATGGAGCATGAAAAAAATTTCTTGTATATTTTTGTATTTCACTGTTTCTAAGGCCCCATTTTTTTCAACCTGTAATGTCTTTGAACTGGGAAGCTCCTTACTCTTCATGATACTGTAGAAGTATAATTGGCAGTGCTGTTTTTCCTTAGTGGAATAGAAAATAATGGTGCATCTTATAGTAGATGGCATCTTAGATTTGATGATTACAGTATTTTGAGTTGCAATAGTAACTGACAGTAAGCTAAAGATAATGGAAAAACGAGTAAAAATTGGGAGGGAGTAGTCAAAGGCATCTAAGTAAAATAAATCATCTTTTTTTTTTTTTTTAGAGACAGGGTCTAGCTCTGTTGCTCAGGCTGGAGTGCAGTGGCGTGCATGATCATAGCTCACTGTAACCTTGAGCTCCTGGGCTCAAGTGATCCTCCTGCCTTAGCTTCCTGAGTAGCTGGGACTACAGGTATGCAACACTGCACCTGGATAATTATTATTATTATTATTATTTTTTTTTTTGTAGAGATGGGGTCTTGCTGTGTTGTCCAGGCTGGTCTTGAACTCCTGGACTCAAGTGATCCTTGAGGCTTGGTGTCCAAAAGCATTGGGATTATAGGCATGAGCCACCATGCCTGCCCTAAACTACCATCTTTTATAGTCAAAGGTCAATAGATGATGTCCACATGTATGTTCACTGCAGTACTATTCACAATAGCAAAGACATGGAATCAACCCAAATGACCATCAATGATAGACCGGATAAAGAAAATGTGATATATATACACCATGGAATACTATGCAGCCGTAAAAACGAATGAGATCATGTCCTTTGCAGGAACATGGGTGGAGCTGGAAGCCATAATCCTCAGCAAACTAACACAGGAACAGAAAACCAAACACCGCATGTTCTTGCTCATAAGTGAGAGCTGCTGAACAATGAGAACACATGGACACAGGGAGGGGAACATCACACACAAGAGGCCGGTTGTGGGTGGGGGTTGGGGGAGAGAGAGAGAGTCAGGATAAATAGCTAATGCATGCTGGGCTTAATACCTAGGTGATAGGTTGACTGGTGCAGCAAACCACCATGGCACATGTTTACCTACGTAACAAACCTGCACATCCTGCACATGTATCCTGGAACTTAAAATAAATAAATAAATAAAATAGATGATGTTCAAATATGACTTTTTTTAAAGGCCTGGCTCTGTGGCTCATGCCTGTAATGCCAGCACTTTGGGAGGCCGAGGCAGGAGGATCGTTTGAGCCCAGGTGTTCAAGACCAGCCGAGGTGACGTAGGAAGACCCTGTCTCTACACACACACACACACACACACACACACACACACACACACACACACACAGAGCAGCATGTTATCTTTTCATTTAAAACCCTTTCACTTTGATTTTTTTAAAAACCATACTGTATTAGTTTCTTATGGCTGCTGTAAAAAATTACCATAAACTTAGCGGCTTAAAACAACAGGAAATTACTTTTTTACAGTTCTGGAGTCCAAAAGTCTGAAATCAAAGTGTGAGCAGGGCCATGTTCCCTCCAGAGCCTCTAGGGTTCTCTGTCTCTTCCAGCTTCGGGTGGCTGCCAGCACTCCTTGACTTGTGGCTTCATCATTGTAGTCTCTGCCTCTGTCTTCCCACTGCCTTCTCTGTGAGTGTTAAATCTCCCTCTACCTTTCTTTTATAAGGATTTATTAGTGCCACGTAGGGCTCACCTGAATAATCCAGGATAATCTAATTTCGAGATTCTTAATTAAATCTGCAAAGAGCCTTTTTCCAAATAAGATAATATTCACAGGTTCTAGGGATTAGAACATGAACATCTCTTTGGGAATCATCATTAGCCTGCCACACATGTATAAGCATTAGTTTGATTTTTAAAAATGAGAAGTTTT-C Preeclampsia not provided (-)157379
17-32605088-T-G not specified Uncertain significance (Jan 20, 2023)2476672
17-32605132-C-T not specified Uncertain significance (Aug 16, 2022)2307160
17-32605138-T-C not specified Uncertain significance (Apr 06, 2024)3297798
17-32605158-G-A Benign (Jan 31, 2018)734200
17-32605165-A-C not specified Uncertain significance (Apr 06, 2024)3297801
17-32653851-C-T not specified Uncertain significance (May 13, 2024)3297797
17-32653875-T-C not specified Uncertain significance (Dec 09, 2023)3163478
17-32653889-C-T not specified Uncertain significance (Jul 06, 2021)2213300
17-32653930-C-G not specified Uncertain significance (Sep 27, 2022)2314088
17-32653950-G-GAA Likely benign (Jan 17, 2024)2798127
17-32653952-AAG-A Likely benign (Jan 17, 2024)2798128
17-32654575-G-A not specified Uncertain significance (Sep 14, 2023)2589620
17-32654595-C-T not specified Uncertain significance (Jan 04, 2024)3163474
17-32659127-G-A not specified Uncertain significance (Jul 14, 2023)2590574
17-32659148-C-T Benign (Dec 31, 2019)781363
17-32659167-G-A Benign (May 01, 2024)710462
17-32659182-C-G not specified Uncertain significance (Nov 07, 2022)2323374
17-32659224-G-A not specified Uncertain significance (Mar 27, 2023)2511214
17-32659236-C-T not specified Uncertain significance (Mar 31, 2024)3297800
17-32659240-G-C not specified Uncertain significance (Dec 28, 2022)2339825
17-32659305-T-C not specified Uncertain significance (Jun 09, 2022)2294369
17-32712028-C-T not specified Uncertain significance (Oct 13, 2023)3163458

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
MYO1Dprotein_codingprotein_codingENST00000318217 22384656
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
1.28e-121.001256550931257480.000370
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense1.364875790.8410.00003446652
Missense in Polyphen159216.130.735672502
Synonymous0.1092072090.9900.00001231870
Loss of Function3.362956.20.5160.00000329638

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.0008670.000867
Ashkenazi Jewish0.0003980.000397
East Asian0.0003830.000381
Finnish0.0004170.000416
European (Non-Finnish)0.0003540.000343
Middle Eastern0.0003830.000381
South Asian0.0003010.000294
Other0.0004980.000489

dbNSFP

Source: dbNSFP

Function
FUNCTION: Myosins are actin-based motor molecules with ATPase activity. Unconventional myosins serve in intracellular movements. Their highly divergent tails are presumed to bind to membranous compartments, which would be moved relative to actin filaments (By similarity). {ECO:0000250}.;

Recessive Scores

pRec
0.154

Intolerance Scores

loftool
rvis_EVS
-0.64
rvis_percentile_EVS
16.71

Haploinsufficiency Scores

pHI
0.888
hipred
Y
hipred_score
0.706
ghis
0.553

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
E
gene_indispensability_score
0.922

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Myo1d
Phenotype

Gene ontology

Biological process
negative regulation of phosphatase activity;forebrain development;cellular localization;early endosome to recycling endosome transport
Cellular component
endosome;smooth endoplasmic reticulum;cytosol;brush border;basolateral plasma membrane;myosin complex;axon;axolemma;cytoplasmic vesicle;neuron projection;neuronal cell body;myelin sheath;plasma membrane raft;extracellular exosome;apical dendrite
Molecular function
microfilament motor activity;calmodulin binding;ATP binding;protein domain specific binding;actin-dependent ATPase activity;calcium-dependent protein binding;actin filament binding